CPhI Online

- Market News

Growing drug delivery CDMO Kindeva expands UK operations

16 Mar 2021

US-headquartered company Kindeva seals deal for an R&D facility at Loughborough’s life sciences hub

Global contract development and manufacturing organisation (CDMO) Kindeva Drug Delivery has expanded its UK operations by securing a deal for an R&D facility and 20,000 sq. ft of office space at its Charnwood Campus site in Loughborough.

Formerly 3M Drug Delivery Systems, Kindeva specialises in drug delivery and combination products for its pharmaceutical and biotechnology customers and currently employs over 500 staff in the UK across its two sites at Loughborough and Clitheroe.

Charnwood Campus is now home to four blue-chip organisations including Almac, 3M, Kindeva, and global diagnostics company PerkinElmer. It is also the first and only Life Sciences Opportunity Zone in the UK and part of the Loughborough and Leicester Science and Innovation Enterprise Zone.

“As a growing CDMO and life sciences company, Kindeva thrives on our base of well-trained, highly-qualified leaders in scientific R&D,” said Aaron Mann, CEO of Kindeva Drug Delivery.

“The Charnwood campus provides a state-of-the-art laboratory design to support our industry-leading talent. Importantly, the proximity to general management offices promotes cross-functional collaboration between our R&D team and other areas of the business, enabling consistent feedback of customer needs and insights into our R&D activities.”

Related Content